| meta-analysis | Q815382 |
| scholarly article | Q13442814 |
| P50 | author | Rustam Al-Shahi Salman | Q55205960 |
| Michael Tin Chung Poon | Q58799610 | ||
| P2093 | author name string | Arthur François Fonville | |
| P2860 | cites work | Developing optimal search strategies for detecting clinically sound prognostic studies in MEDLINE: an analytic survey | Q24798774 |
| Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement | Q27860868 | ||
| Recurrent brain hemorrhage is more frequent than ischemic stroke after intracranial hemorrhage | Q34198532 | ||
| Prior antiplatelet therapy and outcome following intracerebral hemorrhage: a systematic review | Q34455124 | ||
| Long term survival after primary intracerebral haemorrhage: a retrospective population based study | Q35484978 | ||
| Ten year recurrence after first ever stroke in a Japanese community: the Hisayama study | Q35486627 | ||
| Prognosis of stroke in the south of Greece: 1 year mortality, functional outcome and its determinants: the Arcadia Stroke Registry | Q35572151 | ||
| Should a patient with primary intracerebral haemorrhage receive antiplatelet or anticoagulant therapy? | Q36234610 | ||
| Prognosis research strategy (PROGRESS) 1: A framework for researching clinical outcomes | Q36591044 | ||
| Location and outcome of anticoagulant-associated intracerebral hemorrhage | Q36732059 | ||
| Prognostic factors in patients with intracerebral haematoma | Q36966012 | ||
| Worldwide stroke incidence and early case fatality reported in 56 population-based studies: a systematic review | Q37398330 | ||
| Incidence, case fatality, and functional outcome of intracerebral haemorrhage over time, according to age, sex, and ethnic origin: a systematic review and meta-analysis | Q37670468 | ||
| Prediction of death in patients with primary intracerebral hemorrhage: a prospective study of a defined population | Q38487466 | ||
| Incidence, 30-day case-fatality rate, and prognosis of stroke in Iquique, Chile: a 2-year community-based prospective study (PISCIS project). | Q39162691 | ||
| Intracerebral haemorrhage profiles are changing: results from the Dijon population-based study | Q39473342 | ||
| Quality-adjusted life expectancy (QALE) and loss of QALE for patients with ischemic stroke and intracerebral hemorrhage: a 13-year follow-up | Q39901361 | ||
| Change in incidence and aetiology of intracerebral haemorrhage in Oxfordshire, UK, between 1981 and 2006: a population-based study | Q40212101 | ||
| Hemorrhage burden predicts recurrent intracerebral hemorrhage after lobar hemorrhage | Q40518629 | ||
| Influence of clinical factors, CT findings and early management on outcome in supratentorial intracerebral hemorrhage | Q40830095 | ||
| Recurrence of Bleeding in Patients With Primary Intracerebral Hemorrhage | Q40980847 | ||
| The ICH score: a simple, reliable grading scale for intracerebral hemorrhage | Q43503411 | ||
| Incidence of stroke subtypes, prognosis and prevalence of risk factors in Joinville, Brazil: a 2 year community based study | Q43570246 | ||
| Management and Prognostic Features of Intracerebral Hemorrhage During Anticoagulant Therapy: A Swedish Multicenter Study | Q43787550 | ||
| Seizures after primary intracerebral hemorrhage | Q43922587 | ||
| Incidence of stroke subtypes in the North East Melbourne Stroke Incidence Study (NEMESIS): differences between men and women | Q44118914 | ||
| One-year outcome after first-ever stroke according to stroke subtype, severity, risk factors and pre-stroke treatment. A population-based study from Tartu, Estonia. | Q44481914 | ||
| Long-term prognosis after recovery from primary intracerebral hemorrhage | Q44997592 | ||
| Incidence and 10-year survival of intracerebral hemorrhage in a population-based registry. | Q45917332 | ||
| Predictors of outcome in warfarin-related intracerebral hemorrhage | Q46318724 | ||
| Comparison of recovery patterns and prognostic indicators for ischemic and hemorrhagic stroke in China: the ChinaQUEST (QUality Evaluation of Stroke Care and Treatment) Registry study | Q48116541 | ||
| White matter lesions and poor outcome after intracerebral hemorrhage: a nationwide cohort study. | Q48203771 | ||
| Blood Pressure Control and Recurrence of Hypertensive Brain Hemorrhage | Q48398563 | ||
| Management patterns and health care use after intracerebral hemorrhage. a cost-of-illness study from a societal perspective in Germany | Q48420065 | ||
| Three-year survival and stroke recurrence rates in patients with primary intracerebral hemorrhage | Q48467729 | ||
| Impact of seizures on morbidity and mortality after stroke: a Canadian multi-centre cohort study | Q49079219 | ||
| Long-term survival after first-ever stroke: the Oxfordshire Community Stroke Project | Q50609530 | ||
| Recurrent primary intracerebral hemorrhage in Izumo City, Japan | Q50764427 | ||
| The impact of functional status at three months on long-term survival after spontaneous intracerebral hemorrhage | Q50774812 | ||
| Recurrent stroke after lobar and deep intracerebral hemorrhage: a hospital-based cohort study | Q51169308 | ||
| Chronic Kidney Disease in Patients with Acute Intracerebral Hemorrhage: Association with Large Hematoma Volume and Poor Outcome | Q53253920 | ||
| Subtypes and One-Year Survival of First-Ever Stroke in Chinese Patients: The Nanjing Stroke Registry | Q57253824 | ||
| Outcome after spontaneous and arteriovenous malformation-related intracerebral haemorrhage: population-based studies | Q57384707 | ||
| Cause of Stroke Recurrence Is Multifactorial | Q57588221 | ||
| Rate of Stroke Recurrence in Patients With Primary Intracerebral Hemorrhage | Q57757183 | ||
| P433 | issue | 6 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | systematic review | Q1504425 |
| meta-analysis | Q815382 | ||
| P304 | page(s) | 660-667 | |
| P577 | publication date | 2013-11-21 | |
| P1433 | published in | Journal of Neurology, Neurosurgery and Psychiatry | Q1599804 |
| P1476 | title | Long-term prognosis after intracerebral haemorrhage: systematic review and meta-analysis | |
| P478 | volume | 85 |
| Q64449453 | A new era for comorbid cerebral ischaemia and haemorrhage |
| Q99585308 | APOE genotype, hypertension severity and outcomes after intracerebral haemorrhage |
| Q37074302 | APOE polymorphisms influence longitudinal lipid trends preceding intracerebral hemorrhage |
| Q35904756 | APOE ε4 and lipid levels affect risk of recurrent nonlobar intracerebral hemorrhage |
| Q26799042 | Accuracy of the ABC/2 Score for Intracerebral Hemorrhage: Systematic Review and Analysis of MISTIE, CLEAR-IVH, and CLEAR III |
| Q90676872 | Acute hematoma expansion after spontaneous intracerebral hemorrhage: risk factors and impact on long-term prognosis |
| Q36918432 | After Intracerebral Hemorrhage, Oligodendrocyte Precursors Proliferate and Differentiate Inside White-Matter Tracts in the Rat Striatum |
| Q47135583 | Analysis of three surgical treatments for spontaneous supratentorial intracerebral hemorrhage |
| Q55047549 | Anticoagulation Resumption After Intracerebral Hemorrhage. |
| Q30975560 | Anticoagulation for Atrial Fibrillation in Patients with Cerebral Microbleeds |
| Q47314967 | Antiplatelet Resumption after Antiplatelet-Related Intracerebral Hemorrhage: A Retrospective Hospital-Based Study |
| Q24185972 | Antithrombotic treatment after intracerebral haemorrhage |
| Q36379755 | Antithrombotic treatment after stroke due to intracerebral haemorrhage. |
| Q38448388 | Antithrombotic treatment and intracerebral haemorrhage: between Scylla and Charybdis. |
| Q36533789 | Association Between Blood Pressure Control and Risk of Recurrent Intracerebral Hemorrhage |
| Q41811389 | Association between alpha-1 antichymotrypsin gene A/T polymorphism and primary intracerebral hemorrhage: a meta-analysis |
| Q39544827 | Association between diabetes mellitus and the occurrence and outcome of intracerebral hemorrhage. |
| Q40953678 | Association between eye position on brain scan and hospital mortality in acute intracerebral hemorrhage |
| Q99632929 | Association of Selective Serotonin Reuptake Inhibitor Use After Intracerebral Hemorrhage With Hemorrhage Recurrence and Depression Severity |
| Q89807805 | Association of prestroke glycemic status with stroke mortality |
| Q51347093 | Association of promoter polymorphism -857C/T (rs1799724) in tumor necrosis factor gene with intracerebral hemorrhage in Korean males |
| Q64075639 | Automated segmentation of haematoma and perihaematomal oedema in MRI of acute spontaneous intracerebral haemorrhage |
| Q90724519 | Baseline factors associated with early and late death in intracerebral haemorrhage survivors |
| Q41501495 | Blend sign predicts poor outcome in patients with intracerebral hemorrhage. |
| Q50559223 | Blood Pressure Management After Intracerebral Hemorrhage |
| Q39973169 | Blood Pressure Management in Intracranial Hemorrhage: Current Challenges and Opportunities. |
| Q51742398 | Blood Pressure Variability and Outcome in Patients with Acute Nonlobar Intracerebral Hemorrhage following Intensive Antihypertensive Treatment |
| Q92518133 | Blood pressure control and clinical outcomes in acute intracerebral haemorrhage: a preplanned pooled analysis of individual participant data |
| Q59329422 | Blood-Brain Barrier Dysfunction in Small Vessel Disease Related Intracerebral Hemorrhage |
| Q38659385 | Brain hemorrhage recurrence, small vessel disease type, and cerebral microbleeds: A meta-analysis |
| Q47272413 | Cancer is an independent predictor of poor outcomes in patients following intracerebral hemorrhage |
| Q57789140 | Cardioembolic Stroke Risk and Recovery After Anticoagulation-Related Intracerebral Hemorrhage |
| Q47654123 | Causes of Death in Different Subtypes of Ischemic and Hemorrhagic Stroke. |
| Q57067775 | Choices for long-term hypertensive control in patients after first-ever hemorrhagic stroke: a nationwide cohort study |
| Q47913191 | Cognitive Impairment Before Intracerebral Hemorrhage Is Associated With Cerebral Amyloid Angiopathy |
| Q91368428 | Combining Investigation of Imaging Markers (Island Sign and Blend Sign) and Clinical Factors in Predicting Hematoma Expansion of Intracerebral Hemorrhage in the Basal Ganglia |
| Q98158978 | Comparison of Common Methods for Precision Volume Measurement of Hematoma |
| Q37730994 | Convexity subarachnoid haemorrhage has a high risk of intracerebral haemorrhage in suspected cerebral amyloid angiopathy |
| Q42737128 | Cortical superficial siderosis predicts early recurrent lobar hemorrhage |
| Q36044826 | Curcumin attenuates brain edema in mice with intracerebral hemorrhage through inhibition of AQP4 and AQP9 expression |
| Q39561879 | Declining incidence of intracerebral hemorrhage over two decades in a population-based study. |
| Q41635635 | Delayed seizures after intracerebral haemorrhage |
| Q90113326 | Developing an algorithm to identify patients with intracerebral haemorrhage secondary to a macrovascular cause |
| Q48606868 | Distribution of lacunes in cerebral amyloid angiopathy and hypertensive small vessel disease |
| Q90731775 | EIT Imaging of Intracranial Hemorrhage in Rabbit Models Is Influenced by the Intactness of Cranium |
| Q92293152 | Effects of antiplatelet therapy after stroke due to intracerebral haemorrhage (RESTART): a randomised, open-label trial |
| Q92294160 | Effects of antiplatelet therapy on stroke risk by brain imaging features of intracerebral haemorrhage and cerebral small vessel diseases: subgroup analyses of the RESTART randomised, open-label trial |
| Q92823174 | Emerging therapeutic targets associated with the immune system in patients with intracerebral haemorrhage (ICH): From mechanisms to translation |
| Q57384692 | European Stroke Organisation (ESO) Guidelines for the Management of Spontaneous Intracerebral Hemorrhage |
| Q90548523 | Favorable clinical outcome following surgical evacuation of deep-seated and lobar supratentorial intracerebral hemorrhage: a retrospective single-center analysis of 123 cases |
| Q91668646 | Frequent Emergency Department Visits After Spontaneous Intracerebral Hemorrhage: Who Is at Risk? |
| Q27313248 | Genetic deletion of the prostaglandin E2 E prostanoid receptor subtype 3 improves anatomical and functional outcomes after intracerebral hemorrhage |
| Q52583006 | Haemostatic therapies for acute spontaneous intracerebral haemorrhage. |
| Q56343865 | Hypertension and intracerebral hemorrhage recurrence among white, black, and Hispanic individuals |
| Q98226234 | Injectable Gelatin Hydrogel Suppresses Inflammation and Enhances Functional Recovery in a Mouse Model of Intracerebral Hemorrhage |
| Q48097259 | Injury mechanisms in acute intracerebral hemorrhage. |
| Q38526615 | Intracerebral Hemorrhage: A Common and Devastating Disease in Need of Better Treatment |
| Q87873784 | Intracerebral Hemorrhages From Cerebral Arteriovenous Malformations: Prognostic Grading |
| Q57482499 | Intracerebral haemorrhage: current approaches to acute management |
| Q41104753 | Intracerebral hemorrhage at young age: long-term prognosis. |
| Q64115519 | Long-Term Follow-up in Patients with Spontaneous Intracerebral Hemorrhage Treated With or Without Surgical Intervention: a Large-Scale Retrospective Study |
| Q38671522 | Long-term antithrombotic treatment in intracranial hemorrhage survivors with atrial fibrillation |
| Q48235405 | Management of acute intracerebral haemorrhage - an update. |
| Q40478828 | Management of antithrombotic therapy after bleeding in patients with coronary artery disease and/or atrial fibrillation: expert consensus paper of the European Society of Cardiology Working Group on Thrombosis. |
| Q26752952 | Management of intracerebral hemorrhage--use of statins |
| Q39010418 | Medical management of intracerebral haemorrhage. |
| Q90198322 | Meta-analysis of haematoma volume, haematoma expansion and mortality in intracerebral haemorrhage associated with oral anticoagulant use |
| Q42258316 | Minimal invasive puncture and drainage versus endoscopic surgery for spontaneous intracerebral hemorrhage in basal ganglia |
| Q39556840 | Modelling the cost-effectiveness of pharmacist-managed anticoagulation service for older adults with atrial fibrillation in Singapore. |
| Q90559506 | Mortality and recurrent vascular events after first incident stroke: a 9-year community-based study of 0·5 million Chinese adults |
| Q39044323 | One-year disability, death and recurrence after first-ever stroke in a Black Afro-Caribbean population |
| Q54968663 | Optimal long-term antithrombotic management of atrial fibrillation: life cycle management. |
| Q47291019 | Oral Anticoagulation and Functional Outcome after Intracerebral Hemorrhage |
| Q94493464 | Outcome comparison between surgically treated brain arteriovenous malformation hemorrhage and spontaneous intracerebral hemorrhage |
| Q33859442 | Outcome markers for clinical trials in cerebral amyloid angiopathy |
| Q27008354 | Prediction and observation of post-admission hematoma expansion in patients with intracerebral hemorrhage |
| Q35906748 | Prediction and prognostication of neurological deterioration in patients with acute ICH: a hospital-based cohort study |
| Q38787479 | Pretreatment of Mouse Neural Stem Cells with Carbon Monoxide-Releasing Molecule-2 Interferes with NF-κB p65 Signaling and Suppresses Iron Overload-Induced Apoptosis |
| Q55286673 | Prevention of haematoma progression by tranexamic acid in intracerebral haemorrhage patients with and without spot sign on admission scan: a statistical analysis plan of a pre-specified sub-study of the TICH-2 trial. |
| Q39752208 | Prognostic value of perfusion-weighted magnetic resonance imaging in acute intracerebral hemorrhage |
| Q36482822 | Prostaglandin E2 EP2 receptor deletion attenuates intracerebral hemorrhage-induced brain injury and improves functional recovery |
| Q64057477 | Quality of life and depression 3 months after intracerebral hemorrhage |
| Q91931039 | Racial/ethnic disparities in the risk of intracerebral hemorrhage recurrence |
| Q48144369 | Rationale and design of the PreventIon of CArdiovascular events in iSchemic Stroke patients with high risk of cerebral hemOrrhage (PICASSO) study: A randomized controlled trial |
| Q36188813 | Recurrent Intracerebral Hemorrhage: Associations with Comorbidities and Medicine with Antithrombotic Effects |
| Q92293171 | Restarting antiplatelet therapy after intracerebral haemorrhage |
| Q38853708 | Resuming anticoagulant therapy after intracerebral bleeding |
| Q47891553 | Resumption of Anticoagulation After Intracranial Hemorrhage |
| Q40704516 | Risk Factors Associated With Early vs Delayed Dementia After Intracerebral Hemorrhage |
| Q35833463 | Risk Factors for Lobar and Non-Lobar Intracerebral Hemorrhage in Patients with Vascular Disease. |
| Q35877931 | Risk of Ischemic Stroke after Intracranial Hemorrhage in Patients with Atrial Fibrillation |
| Q37642998 | Roles of programmed death protein 1/programmed death-ligand 1 in secondary brain injury after intracerebral hemorrhage in rats: selective modulation of microglia polarization to anti-inflammatory phenotype |
| Q48054847 | Spreading depolarizations in patients with spontaneous intracerebral hemorrhage: Association with perihematomal edema progression |
| Q38532475 | Statins in Intracerebral Hemorrhage |
| Q35501361 | Stem cell therapy in intracerebral hemorrhage rat model |
| Q57312974 | Stroke |
| Q88410644 | Systematic review of the pharmacological agents that have been tested against spreading depolarizations |
| Q90279920 | Ten-year risks of recurrent stroke, disability, dementia and cost in relation to site of primary intracerebral haemorrhage: population-based study |
| Q92215272 | The Intracerebral Hemorrhage Score: Changing Perspectives on Mortality and Disability |
| Q89704396 | The PLAN score can predict poor outcomes of intracerebral hemorrhage |
| Q38527557 | The Pathophysiology of Intracerebral Hemorrhage Formation and Expansion |
| Q64057287 | The REstart or STop Antithrombotics Randomised Trial (RESTART) after stroke due to intracerebral haemorrhage: statistical analysis plan for a randomised controlled trial |
| Q51411516 | The REstart or STop Antithrombotics Randomised Trial (RESTART) after stroke due to intracerebral haemorrhage: study protocol for a randomised controlled trial |
| Q38636940 | The increasing impact of cerebral amyloid angiopathy: essential new insights for clinical practice. |
| Q52660609 | The max-intracerebral hemorrhage score predicts long-term outcome of intracerebral hemorrhage |
| Q91979534 | Treatment of intracranial hemorrhage with neuroendoscopy guided by body surface projection |
Search more.